SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.08-2.7%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (6064)10/15/1998 12:09:00 AM
From: Brander  Read Replies (2) of 9523
 
Concerning the SmartMoney journal article mentioned on this thread recently, following is what it really said about PFE.

The article is titled DREAM STOCKS at Target Prices. They used a quantitative method to determine "a fair--some might say bargain--value for each stock." They listed 10 stocks, along with their bargain buy target. They are as follows:

AOL $75
CSCO $46
KO $40
DELL $33
GE $50
INTC $65
MSFT $64
PFE $46
WMT $34
DIS $22

This article is in the October issue, which came out last month to subscribers. Even considering the sharp market downturn, only one, CSCO, has hit the bargain price. DIS has come close.

The article suggests that there is only a slim chance that these stocks will hit their bargain target buy prices.

If one reads the article, it is clear that what they are saying is that these are dream stocks, and if they ever reach these target prices ("however slim" the chance), one would be advised to load up.

The reason I bring this up, is that the two posts I read on this thread concerning this say that the target prices are fair market value, which is really stretching the true meaning of the article.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext